cGMP peptide manufacturing standards.
Current Good Manufacturing Practice is the regulatory baseline that separates a real wholesale peptide supplier from a reseller. Here is what cGMP actually requires for peptide manufacturing — and how we operate against it.
What cGMP means in practice
cGMP refers to a system of regulations enforced by the U.S. FDA covering manufacturing, processing, packaging, and storage of pharmaceutical products. For peptide manufacturing, the most important cGMP elements are: documented quality systems, validated equipment and processes, lot traceability, in-process and final-release testing, and trained personnel operating to written standard operating procedures.
How we operate
- Documented quality system. All manufacturing partners operate to a written quality manual with controlled SOPs.
- Lot traceability. Every product carries a lot number that traces back to raw-material lots, manufacturing batch records, and release tests.
- Release testing. Identity, HPLC purity, endotoxin, and sterility (where applicable) are tested on every lot before release.
- Trained personnel. Manufacturing partners maintain training records for all production and QA staff.
- Validated processes. Equipment qualification and process validation are maintained per cGMP expectations.
How to verify any supplier’s cGMP claim
- Ask which facility manufactured the product, by name and address.
- Ask whether the facility has been FDA-inspected and what the latest inspection outcome was.
- Ask for a redacted batch record on a recent lot.
- Ask for the supplier’s documented complaint and recall procedures.
- Ask for written quality agreements covering responsibility allocation between the supplier and the manufacturing facility.
If a supplier resists any of those requests, that is an answer in itself. Read more in our guide to cGMP peptide manufacturing.